9 Sarcoma Clinical Trials in Santa Monica, CA (2026)

Q: How do I join a clinical trial in Santa Monica?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Monica research site will contact you.

Recruiting Sarcoma Studies in Santa Monica

NCT03715933Recruiting

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

This is a first-in-human, open-label, non-randomized, three-part phase 1 trial of INBRX-109, which is a recombinant humanized tetravalent antibody targeting the human death receptor 5 (DR5)....

Santa Monica, CAPHASE1411 participantsInhibrx Biosciences, Inc

View Study Details

NCT03016819Recruiting

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)

THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA ONLY AND IS NO LONGER RECRUITING PATIENTS WITH SYNOVIAL SARCOMA OR LEIOMYOSARCOMA. This study evaluates the safety and effi...

Santa Monica, CAPHASE3325 participantsAdvenchen Laboratories, LLC

View Study Details

NCT04535713Recruiting

GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced Sarcoma

This is an open label phase 2 study for advanced sarcoma using metronomic doses of gemcitabine, doxorubicin and docetaxel, and nivolumab immunotherapy given intravenously....

Santa Monica, CAPHASE2260 participantsSarcoma Oncology Research Center, LLC

View Study Details

NCT03138161Recruiting

SAINT:Trabectedin, Ipilimumab and Nivolumab for Previously Treated Advanced Soft Tissue Sarcoma

This is an open label, dose-seeking phase 1/2 study using escalating doses of TRABECTEDIN given intravenously with defined doses of IPILIMUMAB and NIVOLUMAB based on preliminary results of the Checkma...

Santa Monica, CAPHASE1250 participantsSarcoma Oncology Research Center, LLC

View Study Details

NCT05653388Recruiting

Metastatic Leiomyosarcoma Biomarker Protocol

Leiomyosarcoma (LMS) is one of the most prevalent soft tissue sarcomas (STS) and can occur in various sites including soft tissue, uterus and retroperitoneal large vessels. Metastatic disease occurs i...

Santa Monica, CA200 participantsUniversity of Michigan Rogel Cancer Center

View Study Details

NCT03886311Recruiting

Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma

This is a Phase 2 study using talimogene laherparepvec, nivolumab, and trabectedin as first, second or third line therapy for advanced sarcoma, including desmoid tumor and chordoma....

Santa Monica, CAPHASE2200 participantsSarcoma Oncology Research Center, LLC

View Study Details

NCT06127407Recruiting

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

Study CL3-95031-007 (CHONQUER) is a Phase 3, international, multicenter, double-blind, randomized, placebo-controlled study of orally administered ivosidenib. Participants are required to have a histo...

Santa Monica, CAPHASE3136 participantsServier Bio-Innovation LLC

View Study Details

NCT04535271Recruiting

Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma

This is an open label phase 2 study using metronomic doses of trabectedin, gemcitabine and dacarbazine given intravenously....

Santa Monica, CAPHASE280 participantsSarcoma Oncology Research Center, LLC

View Study Details

NCT05876715Recruiting

LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma

This is an open label, dose-seeking phase 1/2 study using escalating doses of LURBINECTEDIN administered intravenously with fixed doses of IPILIMUMAB and NIVOLUMAB administered intravenously....

Santa Monica, CAPHASE140 participantsERLINDA M GORDON

View Study Details

About Sarcoma Clinical Trials in Santa Monica

Sarcomas are rare cancers that arise in bone and soft tissues including muscle, fat, blood vessels, and connective tissue. There are more than 70 subtypes of sarcoma. Treatment usually involves surgery combined with radiation and/or chemotherapy.

There are currently 9 sarcoma clinical trials recruiting participants in Santa Monica, CA. These studies are seeking a combined 1,902 participants. Research is being sponsored by Inhibrx Biosciences, Inc, Advenchen Laboratories, LLC, Sarcoma Oncology Research Center, LLC and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Sarcoma Clinical Trials in Santa Monica — FAQ

Are there sarcoma clinical trials in Santa Monica?

Yes, there are 9 sarcoma clinical trials currently recruiting in Santa Monica, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Santa Monica?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Santa Monica research site will contact you about next steps.

Are clinical trials in Santa Monica free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Santa Monica studies also compensate for your time and travel.

What sarcoma treatments are being tested?

The 9 active trials in Santa Monica are testing new therapies including novel drugs, biologics, and treatment approaches for sarcoma.

Data updated July 19, 2026 from ClinicalTrials.gov